WallStSmart

Kimberly-Clark Corporation (KMB)vsBeauty Health Co (SKIN)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Kimberly-Clark Corporation generates 5368% more annual revenue ($16.45B vs $300.79M). KMB leads profitability with a 12.3% profit margin vs -3.2%. SKIN appears more attractively valued with a PEG of 0.95. KMB earns a higher WallStSmart Score of 52/100 (C-).

KMB

Buy

52

out of 100

Grade: C-

Growth: 3.3Profit: 7.5Value: 6.0Quality: 4.0
Piotroski: 3/9Altman Z: 2.19

SKIN

Hold

43

out of 100

Grade: D

Growth: 2.7Profit: 2.5Value: 6.7Quality: 5.0
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

KMBUndervalued (+9.3%)

Margin of Safety

+9.3%

Fair Value

$118.58

Current Price

$99.36

$19.22 discount

UndervaluedFair: $118.58Overvalued

Intrinsic value data unavailable for SKIN.

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

KMB1 strengths · Avg: 10.0/10
Return on EquityProfitability
126.6%10/10

Every $100 of equity generates 127 in profit

SKIN2 strengths · Avg: 8.0/10
PEG RatioValuation
0.958/10

Growing faster than its price suggests

Price/BookValuation
2.3x8/10

Reasonable price relative to book value

Areas to Watch

KMB4 concerns · Avg: 2.3/10
Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

PEG RatioValuation
6.892/10

Expensive relative to growth rate

Price/BookValuation
21.9x2/10

Trading at 21.9x book value

Revenue GrowthGrowth
-0.6%2/10

Revenue declined 0.6%

SKIN4 concerns · Avg: 3.0/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$148.22M3/10

Smaller company, higher risk/reward

Operating MarginProfitability
0.2%3/10

Operating margin of 0.2%

Return on EquityProfitability
-16.9%2/10

ROE of -16.9% — below average capital efficiency

Comparative Analysis Report

WallStSmart Research

Bull Case : KMB

The strongest argument for KMB centers on Return on Equity.

Bull Case : SKIN

The strongest argument for SKIN centers on PEG Ratio, Price/Book. PEG of 0.95 suggests the stock is reasonably priced for its growth.

Bear Case : KMB

The primary concerns for KMB are Piotroski F-Score, PEG Ratio, Price/Book. Debt-to-equity of 4.77 is elevated, increasing financial risk.

Bear Case : SKIN

The primary concerns for SKIN are EPS Growth, Market Cap, Operating Margin.

Key Dynamics to Monitor

KMB profiles as a declining stock while SKIN is a turnaround play — different risk/reward profiles.

SKIN carries more volatility with a beta of 1.21 — expect wider price swings.

KMB is growing revenue faster at -0.6% — sustainability is the question.

KMB generates stronger free cash flow (575M), providing more financial flexibility.

Bottom Line

KMB scores higher overall (52/100 vs 43/100). Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Kimberly-Clark Corporation

CONSUMER DEFENSIVE · HOUSEHOLD & PERSONAL PRODUCTS · USA

Kimberly-Clark Corporation is an American multinational personal care corporation that produces mostly paper-based consumer products. The company manufactures sanitary paper products and surgical & medical instruments. Kimberly-Clark brand name products include Kleenex facial tissue, Kotex feminine hygiene products, Cottonelle, Scott and Andrex toilet paper, Wypall utility wipes, KimWipes scientific cleaning wipes and Huggies disposable diapers and baby wipes.

Visit Website →

Beauty Health Co

CONSUMER DEFENSIVE · HOUSEHOLD & PERSONAL PRODUCTS · USA

Edge Systems, LLC designs, develops, manufactures, markets and sells aesthetic products and technologies. The company is headquartered in Signal Hill, California with a location in Long Beach, California.

Want to dig deeper into these stocks?